Literature DB >> 32645336

Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.

Farrokh Sharifi1, Andrew Otte1, Gwangheum Yoon2, Kinam Park3.   

Abstract

Injectable, long-acting drug delivery systems provide effective drug concentrations in the blood for up to 6 months. Naltrexone-loaded poly(lactide-co-glycolide) (PLGA) microparticles were prepared using an in-line homogenization method. It allows the transition from a laboratory scale to scale-up production. This research was designed to understand how the processing parameters affect the properties of the microparticles, such as microparticle size distributions, surface and internal morphologies, drug loadings, and drug release kinetics, and thus, to control them. The in-line homogenization system was used at high flow rates for the oil- and water-phases, e.g., 100 mL/min and 400 mL/min, respectively, to continuously generate microparticles. A high molecular weight (148 kDa) PLGA at various concentrations was used to generate oil-phases with a range of viscosities and also to compare with a 64 and 79 kDa at a single, high concentration. The uniformity of the microparticles was found to be related to the viscosity of the oil-phase. As the viscosity of the oil-phase increased from 52.6 mPa∙s to 4046 mPa∙s, the span value (a measure of uniformity) increased from 1.24 to 3.1 for the microparticles generated at the homogenization speed of 2000 RPM. Increasing the PLGA concentration from 5.58% to 16.85% showed a corresponding rise in the encapsulation efficiency from 74.0% to 85.8% and drug loading (DL) from 27.4% to 31.7% for the microparticles made with the homogenization speed of 2000 RPM. These increases may be due to a faster shell formulation, enabling PLGA microparticles to entrap more naltrexone into the structure. A higher DL, however, shortened the drug release duration from 56 to 42 days. The changes in morphology of the microparticles during different phases of the in vitro release study were also studied for three types of microparticles made with different PLGA concentrations and molecular weights. As PLGA microparticles went through structural changes, the surface showed raisin-like wrinkled morphologies within the first 10 days. Then, the microparticles swelled to form smooth surfaces. The in-line approach produced PLGA microparticles with a highly reproducible size distribution, DL, and naltrexone release rate.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug loading; Encapsulation efficiency; In-line homogenization; Naltrexone; Oil-phase viscosity; PLGA microparticles

Mesh:

Substances:

Year:  2020        PMID: 32645336      PMCID: PMC7434690          DOI: 10.1016/j.jconrel.2020.06.023

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   11.467


  44 in total

1.  PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release.

Authors:  N Faisant; J Siepmann; J P Benoit
Journal:  Eur J Pharm Sci       Date:  2002-05       Impact factor: 4.384

2.  Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.

Authors:  Archana Rawat; Diane J Burgess
Journal:  Int J Pharm       Date:  2010-05-22       Impact factor: 5.875

Review 3.  Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations.

Authors:  C Thomasin; N T Hô; H P Merkle; B Gander
Journal:  J Pharm Sci       Date:  1998-03       Impact factor: 3.534

4.  Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Authors:  R Jeyanthi; R C Mehta; B C Thanoo; P P DeLuca
Journal:  J Microencapsul       Date:  1997 Mar-Apr       Impact factor: 3.142

5.  Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.

Authors:  H Gasmi; F Danede; J Siepmann; F Siepmann
Journal:  J Control Release       Date:  2015-07-03       Impact factor: 9.776

6.  Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation.

Authors:  Kinam Park; Sarah Skidmore; Justin Hadar; John Garner; Haesun Park; Andrew Otte; Bong Kwan Soh; Gwangheum Yoon; Dijia Yu; Yeonhee Yun; Byung Kook Lee; Xiaohui Jiang; Yan Wang
Journal:  J Control Release       Date:  2019-05-06       Impact factor: 9.776

7.  Agglomeration of wet particles in dense granular flows.

Authors:  Thanh Trung Vo; Saeid Nezamabadi; Patrick Mutabaruka; Jean-Yves Delenne; Edouard Izard; Roland Pellenq; Farhang Radjai
Journal:  Eur Phys J E Soft Matter       Date:  2019-09-18       Impact factor: 1.890

8.  In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.

Authors:  Jie Shen; Stephanie Choi; Wen Qu; Yan Wang; Diane J Burgess
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

9.  Incorporation of water-soluble drugs in PLGA microspheres.

Authors:  Fuminori Ito; Hiroyuki Fujimori; Kimiko Makino
Journal:  Colloids Surf B Biointerfaces       Date:  2006-10-26       Impact factor: 5.268

10.  Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.

Authors:  Xiangrong Song; Yu Zhao; Shixiang Hou; Fangyuan Xu; Rongli Zhao; Junyao He; Zheng Cai; Yuanbo Li; Qiuhong Chen
Journal:  Eur J Pharm Biopharm       Date:  2008-01-19       Impact factor: 5.571

View more
  7 in total

1.  Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing.

Authors:  Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2022-06-28       Impact factor: 11.467

2.  Implications of particle size on the respective solid-state properties of naltrexone in PLGA microparticles.

Authors:  Andrew Otte; Hazal Turasan; Kinam Park
Journal:  Int J Pharm       Date:  2022-09-05       Impact factor: 6.510

Review 3.  Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.

Authors:  Kinam Park; Andrew Otte; Farrokh Sharifi; John Garner; Sarah Skidmore; Haesun Park; Young Kuk Jhon; Bin Qin; Yan Wang
Journal:  J Control Release       Date:  2020-10-24       Impact factor: 11.467

4.  Initial Formation of the Skin Layer of PLGA Microparticles.

Authors:  Farrokh Sharifi; Andrew Otte; Kinam Park
Journal:  Adv Healthc Mater       Date:  2021-10-19       Impact factor: 11.092

5.  Key Factor Study for Generic Long-Acting PLGA Microspheres Based on a Reverse Engineering of Vivitrol®.

Authors:  Yabing Hua; Zengming Wang; Dan Wang; Xiaoming Lin; Boshi Liu; Hui Zhang; Jing Gao; Aiping Zheng
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

6.  Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose.

Authors:  Farrokh Sharifi; Yazan J Meqbil; Andrew Otte; Anna M Gutridge; Arryn T Blaine; Richard M van Rijn; Kinam Park
Journal:  Pharm Res       Date:  2021-06-10       Impact factor: 4.580

Review 7.  Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.

Authors:  Yabing Hua; Yuhuai Su; Hui Zhang; Nan Liu; Zengming Wang; Xiang Gao; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.